NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica®, Inc. (NASDAQ: BIOC), a global provider of clinical trial management and technology solutions, today announced its financial results for the third quarter and nine months ended September 30, 2011.
Financial highlights for the three months ended September 30, 2011 include:
•Service revenues increased 4.1% to $16.6 million as compared with $16.0 million for the same period in 2010.
Financial highlights for the three months ended September 30, 2011 include:
•Service revenues increased 4.1% to $16.6 million as compared with $16.0 million for the same period in 2010.
